Latest News

Syngenta ditches multi-billion dollar China IPO quote

Swiss agrichemicals and seeds group Syngenta on Friday withdrew its quote for a. multibillion dollar listing on the Shanghai Stock Market. throughout a recent duration of weakness in the Chinese equity market.

The initial public offering (IPO), which would have valued. the Chinese-owned firm at as much as $60 billion, has been. held off consistently since being proposed in 2021 due to. damaging market conditions.

After careful factor to consider of industry environment and the. business's own advancement strategy, Syngenta Group has actually decided. to withdraw its application for IPO on the main board of the. Shanghai Stock Exchange, the company stated on Friday.

The flotation had, like other recent deals, come unstuck due. to a lull on the Chinese market, according to a person familiar. with the matter, who spoke on condition of anonymity.

Syngenta representative Saswato Das decreased to give even more. information on why the business had gone back from the IPO.

Syngenta stated it will aim to restart the listing process. either in China or on a various exchange, when conditions are. right, along with check out alternative sources of funding.

Market experts have actually formerly mentioned Hong Kong, Zurich and. London as potential alternatives for a Syngenta listing.

The sudden chill in China's IPO market, which was the. world's biggest in 2022 and 2023, comes after the securities. watchdog, under brand-new chairman Wu Qing, pledged to step up scrutiny. of listing prospects and punish any lapses.

During January-March 2024, cash raised via China IPOs. plunged two-thirds from a year previously to just $2.4 billion, the. smallest quarterly fundraising since the last quarter of 2018,. and down 82% from a year previously, initial LSEG information revealed.

Executives of the company owned by Sinochem stated as just recently. as last November that Syngenta planned to list in 2024. The. partial floatation was anticipated to raise around $10 billion.

The Shanghai Exchange said in a filing that the bourse had. terminated its review of Syngenta's IPO application after the. business used to withdraw it.

Weak need in crucial markets such as Brazil has put pressure. on the company's profits.

Sales at the Basel-based business dipped in 2015 by 4% to. $ 32.2 billion from $33.4 billion in 2022, while earnings before. interest, tax, depreciation and amortisation fell by 18% to $4.6. billion, Syngenta stated later Friday.

(source: Reuters)